CUL7
CUL7[edit]
CUL7 is a gene that encodes a protein known as Cullin 7, which is part of the cullin family of proteins. These proteins are involved in the ubiquitin-proteasome system, a critical pathway for protein degradation and regulation within the cell.
Structure[edit]
The CUL7 protein is a member of the cullin family, which are scaffold proteins that assemble multi-subunit ubiquitin ligase complexes. These complexes are responsible for targeting specific proteins for ubiquitination and subsequent degradation by the proteasome. The CUL7 protein contains several domains, including a cullin homology domain and a C-terminal domain that interacts with other components of the ubiquitin ligase complex.
Function[edit]
CUL7 plays a crucial role in the regulation of cell growth and development. It is involved in the ubiquitination of specific substrates, marking them for degradation. This process is essential for maintaining cellular homeostasis and regulating various cellular processes, including the cell cycle, signal transduction, and apoptosis.
CUL7 forms a complex with other proteins, such as FBXW8 and SKP1, to form an E3 ubiquitin ligase complex. This complex is responsible for the ubiquitination of target proteins, which are then recognized and degraded by the proteasome.
Clinical Significance[edit]
Mutations in the CUL7 gene have been associated with a rare genetic disorder known as 3-M syndrome. This syndrome is characterized by pre- and postnatal growth retardation, facial dysmorphism, and skeletal abnormalities. The disorder is inherited in an autosomal recessive manner, and individuals with mutations in CUL7 exhibit a range of clinical features associated with impaired growth and development.
Research has also suggested that CUL7 may play a role in cancer biology. Alterations in the expression or function of CUL7 have been observed in various types of cancer, indicating that it may have a role in tumorigenesis.
Interactions[edit]
CUL7 interacts with several other proteins to form functional complexes. Notably, it interacts with FBXW8, a member of the F-box protein family, which is involved in substrate recognition. CUL7 also interacts with SKP1, another component of the SCF (SKP1-CUL1-F-box protein) complex, which is a type of E3 ubiquitin ligase complex.
See Also[edit]
References[edit]
External Links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian